• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用免疫放射分析测定血清甲状腺球蛋白对分化型甲状腺癌患者进行随访。与I-131全身扫描的比较。

Follow-up of patients with differentiated thyroid cancer using serum thyroglobulin measured by an immunoradiometric assay. Comparison with I-131 total body scans.

作者信息

McDougall I R, Bayer M F

出版信息

J Nucl Med. 1980 Aug;21(8):741-4.

PMID:7400830
Abstract

An immunoradiometric assay for thyroglobulin (Tg), which allows quantification of Tg in the presence of anti- Tg, has been evaluated in patients with differentiated thyroid cancer. All patients had undergone thyroidectomy plus I- 131 ablation. Three separate studies have been conducted. 1. Tg levels were compared with I- 131 whole-body scans made at 48 hr in 22 patient studies. Both tests gave similar results in 19 of the studies, but in three patients the results of the tests were discordant. 2. Tg levels were compared with clinical status in 18 patients who were free of disease; 15 had Tg values < 5 ng/ml, and three had measurable but normal Tg values. Three patients with metastatic disease had measurable Tg, and in two the values were above normal. 3. Sequential Tg measurements were made at intervals of 3 mo in 19 patients on thyroxine. Fifteen of these patients had identical results on two or more occasions.

摘要

一种用于甲状腺球蛋白(Tg)的免疫放射分析方法,该方法能够在存在抗Tg的情况下对Tg进行定量分析,已在分化型甲状腺癌患者中进行了评估。所有患者均接受了甲状腺切除术加碘-131消融治疗。共进行了三项独立研究。1. 在22例患者研究中,将Tg水平与48小时时进行的碘-131全身扫描结果进行比较。在19项研究中,两项检测结果相似,但在3例患者中,检测结果不一致。2. 将18例无疾病患者的Tg水平与临床状况进行比较;15例患者的Tg值<5 ng/ml,3例患者的Tg值可测量但正常。3例有转移疾病的患者Tg可测量,其中2例的值高于正常水平。3. 对19例服用甲状腺素的患者每隔3个月进行一次连续的Tg测量。其中15例患者在两次或更多次测量中结果相同。

相似文献

1
Follow-up of patients with differentiated thyroid cancer using serum thyroglobulin measured by an immunoradiometric assay. Comparison with I-131 total body scans.采用免疫放射分析测定血清甲状腺球蛋白对分化型甲状腺癌患者进行随访。与I-131全身扫描的比较。
J Nucl Med. 1980 Aug;21(8):741-4.
2
The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.在全甲状腺切除和放射性碘消融治疗后甲状腺癌分化型患者中,抗甲状腺球蛋白抗体阳性且甲状腺功能正常的患者随访期间血清促甲状腺激素升高时,诊断性全身扫描和血清甲状腺球蛋白的价值。
Thyroid. 2012 Feb;22(2):113-6. doi: 10.1089/thy.2011.0020. Epub 2012 Jan 6.
3
Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.血清甲状腺球蛋白及碘-131全身扫描在转移性分化型甲状腺癌的诊断及治疗评估中的应用
J Nucl Med. 1994 Feb;35(2):257-62.
4
Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.血清甲状腺球蛋白在分化型甲状腺癌治疗后患者随访中的应用
J Clin Endocrinol Metab. 1994 Jul;79(1):98-105. doi: 10.1210/jcem.79.1.8027262.
5
[Serum thyroglobulin and whole-body scanning as markers in the follow-up of differentiated thyroid carcinomas].
Medicina (B Aires). 1991;51(4):291-5.
6
Value of repeat stimulated thyroglobulin testing in patients with differentiated thyroid carcinoma considered to be free of disease in the first year after ablation.分化型甲状腺癌患者消融治疗后 1 年内无病状态下重复刺激甲状腺球蛋白检测的价值。
Thyroid. 2012 May;22(5):482-6. doi: 10.1089/thy.2011.0214. Epub 2011 Dec 16.
7
Is serum thyroglobulin a useful marker for thyroid cancer in patients who have not had ablation of residual thyroid tissue?
Thyroid. 1997 Jun;7(3):343-6. doi: 10.1089/thy.1997.7.343.
8
[Thyroglobulin as a tumor marker and thallium scintigraphy for the course control of differentiated thyroid cancer].[甲状腺球蛋白作为肿瘤标志物及铊闪烁扫描术用于分化型甲状腺癌病程监测]
Schweiz Med Wochenschr. 1983 Mar 5;113(9):325-7.
9
Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.分化型甲状腺癌随访中甲状腺球蛋白mRNA定量检测的评估
Thyroid. 2003 Sep;13(9):867-72. doi: 10.1089/105072503322401069.
10
Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.左甲状腺素对分化型甲状腺癌患者甲状腺球蛋白的抑制作用
J Clin Endocrinol Metab. 1999 Dec;84(12):4549-53. doi: 10.1210/jcem.84.12.6190.

引用本文的文献

1
Management of thyroglobulin positive/whole-body scan negative: is Tg positive/131I therapy useful?
J Endocrinol Invest. 2001 Mar;24(3):194-8. doi: 10.1007/BF03343843.
2
The value of serum thyroglobulin measurement as a marker of cancer recurrence in the follow-up of patients previously treated for differentiated thyroid tumor.
J Endocrinol Invest. 1982 Jan-Feb;5(1):43-6. doi: 10.1007/BF03350481.
3
Immunoreactive thyroglobulin in sera and saliva of patients with various thyroid disorders: role of autoantibodies.各种甲状腺疾病患者血清和唾液中的免疫反应性甲状腺球蛋白:自身抗体的作用
J Endocrinol Invest. 1989 Mar;12(3):177-82. doi: 10.1007/BF03349955.